These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 517534)

  • 41. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial endotoxin retention by inline intravenous filters.
    Baumgartner TG; Schmidt GL; Thakker KM; Sitren HS; Cerda JJ; Mahaffey SM; Copeland EM
    Am J Hosp Pharm; 1986 Mar; 43(3):681-4. PubMed ID: 3518429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 44. Recommended procedures for in-use testing of large volume parenterals suspected of contamination or of producing a reaction in a patient. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1978 Jun; 35(6):678-82. PubMed ID: 665681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An in vitro analysis of microbial transmission during EUS-guided FNA and the utility of sterilization agents.
    Sing J; Erickson R; Fader R
    Gastrointest Endosc; 2006 Nov; 64(5):774-9. PubMed ID: 17055873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Control of pediatric nosocomial bacteremia by a program based on culturing of parenteral solutions in use].
    Muñoz JM; Macías AE; Guerrero FJ; Hernández I; Medina H; Vargas E
    Salud Publica Mex; 1999; 41 Suppl 1():S32-7. PubMed ID: 10608175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lorazepam solubility in and sorption from intravenous admixture solutions.
    Newton DW; Narducci WA; Leet WA; Ueda CT
    Am J Hosp Pharm; 1983 Mar; 40(3):424-7. PubMed ID: 6133447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osmolality of small-volume i.v. admixtures for pediatric patients.
    Santeiro ML; Sagraves R; Allen LV
    Am J Hosp Pharm; 1990 Jun; 47(6):1359-64. PubMed ID: 2368732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recycled unused piggyback admixtures through the use of tamper-proof safety caps.
    Jennings RH; Schad RF; Kaurich J
    Hosp Pharm; 1982 Dec; 17(12):643-5, 652. PubMed ID: 10257924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of the efficacy of 3 methods of testing for the sterility of eye ointments with antibiotics].
    Braginskaia PS; Tikhonova AS; Chaĭkovskaia SM
    Antibiotiki; 1976 Feb; 21(2):118-22. PubMed ID: 776070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Particulate contamination of amino acid solutions for parenteral use].
    Ferrari F; Bonferoni MC; Zamella C; La Manna A; Verrengio B; Pedroni M; Omodei-Sale A
    Boll Chim Farm; 1991 Nov; 130(10):402-8. PubMed ID: 1805875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality control in admixture services.
    Zellmer WA
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract]   [Full Text] [Related]  

  • 55. Growth of bacteria in intravenous fluids under stimulated actual-use conditions.
    Hugbo PG; Imhanlahimi WA
    Am J Hosp Pharm; 1983 Jun; 40(6):998-1001. PubMed ID: 6408922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stability of nizatidine in commonly used intravenous fluids and containers.
    Raineri DL; Cwik MJ; Rodvold KA; Deyo KL; Scaros LP; Fischer JH
    Am J Hosp Pharm; 1988 Jul; 45(7):1523-9. PubMed ID: 3137816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability and sterility of cimetidine admixtures frozen in minibags.
    Walker SE; Paton TW; Fabian TM; Liu CC; Coates PE
    Am J Hosp Pharm; 1981 Jun; 38(6):881-3. PubMed ID: 7246565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osmolality of small-volume intravenous admixtures.
    Wermeling DP; Rapp RP; DeLuca PP; Piecoro JJ
    Am J Hosp Pharm; 1985 Aug; 42(8):1739-44. PubMed ID: 4036971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intropin (dopamine hydrochloride) intravenous admixture compatibility, Part 3: stability with miscellaneous additives.
    Gardella LA; Kesler H; Amann A; Carter JE
    Am J Hosp Pharm; 1978 May; 35(5):581-4. PubMed ID: 655182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Droperidol stability in intravenous admixtures.
    Ray JB; Newton DW; Nye MT; Leet WA
    Am J Hosp Pharm; 1983 Jan; 40(1):94-7. PubMed ID: 6823997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.